Chemical topology provides a unique dimension for making therapeutic protein bioconjugates with native structure and intact function, yet the effects of topology remain elusive. Herein, the design, synthesis, and characterization of therapeutic protein bioconjugates in three topologies (i.e., tadpole, macrocycle, and figure‐of‐eight), are reported. The interferon α2b (IFN) and albumin binding domain (ABD) are selected as the model proteins for bioconjugation and proof‐of‐concept. The biosynthesis of these topological isoforms is accomplished via direct expression in cells using SpyTag‐SpyCatcher chemistry and/or split‐intein‐mediated ligation for topology diversification. The corresponding topologies are proven with combined techniques of LC‐MS, SDS‐PAGE, and controlled proteolytic digestion. While the properties of these topological isoforms are similar in most cases, the figure‐of‐eight‐shaped bioconjugate, f8‐IFN‐ABD, exhibits the best thermal stability and anti‐aggregation properties along with prolonged half‐life and enhanced tumor retention relative to the tadpole‐shaped control, tadp‐IFN‐ABD, and the macrocyclic control, c‐IFN‐ABD, showcasing considerable topological effects. The work expands the topological diversity of proteins and demonstrates the potential advantages of leveraging chemical topology for functional benefits beyond multi‐function integration in protein therapeutics.